Russ v. Nike: Plant Biology Patent Claim Dismissed With Prejudice in 82 Days
Jamaal Russ filed suit against Nike in the Oregon District Court asserting US6639128B1, a patent covering methods for altering organ mass and controlling fertility in plants. The case ended when the court dismissed all claims with prejudice under FRCP 41(b) after Russ failed to amend his petition following an earlier dismissal with leave to amend — closing the matter permanently in just 82 days.
Pro Se Plant Patent Suit Against Nike Ends in Permanent Dismissal
On 22 May 2025, Jamaal Russ, appearing to proceed pro se, filed an infringement action in the U.S. District Court for the District of Oregon (Case No. 3:25-cv-00876) against Nike. The asserted patent, US6639128B1 (application no. US09/479855), covers methods for altering organ mass, controlling fertility, and enhancing asexual reproduction in plants — a technical domain that appears facially incongruent with Nike’s core consumer goods and footwear business.
Judge Karin J. Immergut first dismissed the petition with leave to amend (ECF 14), providing Russ an opportunity to cure deficiencies in the pleading. Russ did not file an amended petition. The court accordingly entered final judgment dismissing all claims with prejudice under Federal Rule of Civil Procedure 41(b) for failure to prosecute. A dismissal with prejudice under Rule 41(b) operates as an adjudication on the merits, permanently foreclosing Russ from re-filing the same claims against Nike in any federal court.
The 82-day lifespan of this case is consistent with early-stage dismissals where a complaint fails to survive initial judicial scrutiny. The public record does not disclose the specific pleading deficiencies identified in ECF 14, nor Nike’s litigation response, if any. What is notable is that the court extended a curative opportunity that went unused — suggesting the claim may have faced fundamental sufficiency issues that the plaintiff could not or chose not to address.
Filing to Dismissed with Prejudice in 82 days
82 days — well below the median federal patent case duration of 2–3 years
Dismissed with prejudice: what the Rule 41(b) ruling means for both parties
Rule 41(b) dismissal with prejudice: the claim is permanently closed
FRCP 41(b) empowers a court to dismiss an action with prejudice when a plaintiff fails to prosecute or comply with a court order. Unlike a voluntary dismissal, this is an involuntary court-ordered termination. Critically, a Rule 41(b) dismissal with prejudice operates as a final adjudication on the merits — Russ cannot refile these claims against Nike in federal court based on the same patent and alleged conduct.
Involuntary dismissal — merits barRuss loses all claims permanently — no further avenue on these facts
The dismissal with prejudice extinguishes Russ’s ability to reassert US6639128B1 against Nike for the alleged infringing conduct at issue. The court granted leave to amend, but the opportunity was not taken. The public record does not explain why Russ failed to amend, but the outcome is unambiguous: the claims are permanently barred. Any future assertion against Nike would need to be grounded in entirely new facts or a separate patent.
Claims permanently extinguishedNike prevails without recorded substantive defence costs
Nike emerges from this case with a final judgment in its favour. Because dismissal was entered on procedural failure-to-prosecute grounds rather than following contested merits proceedings, Nike’s litigation exposure was minimal. No defendant agents or law firm are recorded in the public docket, suggesting the case may have resolved before Nike mounted a formal defence. The with-prejudice bar protects Nike from re-exposure on the same claims.
Defendant protected by prejudice barMinimal IP risk to Nike — but plant patent enforcement patterns warrant monitoring
This case presents no apparent commercial IP risk to Nike given the subject matter disconnect between a plant biology methods patent and a footwear/apparel business. However, the case is a reminder that any patent holder — including those asserting facially incongruent patents — can initiate costly litigation. Companies with large Oregon-based operations should maintain docket monitoring for unusual patent filings as part of routine IP risk hygiene.
Low commercial IP risk to NikeFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Jamaal Russ | Individual | Pro se litigant — holder of US6639128B1 covering plant biology methodsSearch in Eureka ↗ |
| Defendant | Nike | Individual | Nike — global footwear and athletic apparel company headquartered in OregonSearch in Eureka ↗ |
| Plaintiff counsel | Jamaal Russ | Attorney | Counsel for Jamaal RussSearch in Eureka ↗ |
| Presiding judge | Judge Karin J. Immergut | Judge | Oregon District CourtSearch in Eureka ↗ |
Official order — verbatim text
The verdict language is precise and consequential: the court first issued an order dismissing the petition with leave to amend (ECF 14), establishing that the original complaint was substantively deficient. Russ’s subsequent inaction triggered Rule 41(b), which treats failure to comply with a court order as grounds for final dismissal. The with-prejudice designation means the judgment carries full claim-preclusive effect — identical claims against Nike arising from the same patent and conduct cannot be re-filed. No merits ruling on US6639128B1’s validity or Nike’s alleged infringement was reached.
US6639128B1 — Methods for altering organ mass and plant fertility
US6639128B1 (application no. US09/479855) is a utility patent covering methods directed at altering organ mass, controlling fertility, and enhancing asexual reproduction in plants. This falls within the agricultural biotechnology and plant science domain — an area with commercial relevance to seed companies, agrochemical firms, and horticultural biotechnology developers. The patent’s technical claims relate to biological manipulation of plant physiology rather than industrial manufacturing or consumer goods.
The strategic relevance of US6639128B1 lies primarily in the agricultural biotech sector, not consumer apparel. For IP professionals, this case is a reminder that patents can be asserted outside their natural competitive landscape. Organisations operating in plant science, precision agriculture, or seed technology sectors should conduct freedom-to-operate assessments against this patent, particularly given that no merits ruling was reached in this case — leaving the patent’s validity and enforceability legally unexamined by this court.
Should you run an FTO analysis against US6639128B1?
Any company developing, commercialising, or licensing technologies related to plant organ mass modification, fertility control, or asexual propagation enhancement should assess exposure to US6639128B1. The patent’s validity was never adjudicated in Russ v. Nike — meaning it remains nominally enforceable. Agricultural biotech firms, seed developers, and horticultural technology companies should treat this as a live FTO consideration until a reexamination or inter partes review determines otherwise.
PatSnap Eureka’s FTO Search Agent can map US6639128B1’s independent claims against your product or process workflow, identify prior art that may challenge claim validity, and surface any related continuation or divisional filings in the same patent family. Running an Eureka FTO analysis before launching plant biotechnology products reduces the risk of facing infringement assertions — even procedurally weak ones that impose real litigation costs before dismissal.
Run a freedom-to-operate analysis on US6639128B1 to assess your product’s exposure
Run FTO in Eureka →Similar plant biology patent suits in Oregon federal courts
Explore comparable patent infringement cases involving plant science and agricultural biotechnology patents filed in the Oregon District Court and Ninth Circuit.
Related patent case — similar technology
Comparable case in the same technology domain. Patent holder and defendant reached resolution after proceedings.
SettledRelated infringement action — same court
Comparable Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants-adjacent infringement action. Patent enforcement dynamics analysed in depth.
Active · District CourtRelated invalidity challenge — appellate outcome
Combined invalidity and infringement action in the same technology space. Decided after substantive proceedings.
DecidedJamaal Russ’s broader IP enforcement history
Jamaal Russ’s full litigation history covering prior enforcement, licensing activity, and inter partes review proceedings.
Portfolio viewWhat this case signals for the patent enforcement IP landscape
A 82-day dismissal with prejudice after failed amendment illustrates how quickly federal courts can close out deficient pro se patent suits.
Courts will grant curative leave to amend — but failure to act is permanently fatal
Judge Immergut’s decision to dismiss with leave to amend before entering Rule 41(b) judgment reflects standard due-process practice. However, once that window closes unused, the prejudice bar is absolute. IP defendants facing pro se suits should monitor amendment deadlines closely — non-compliance typically triggers swift final dismissal without further merits exposure.
Subject-matter incongruence does not prevent a lawsuit from being filed
US6639128B1 covers plant biology methods. Nike makes footwear and apparel. The technological disconnect did not prevent this suit from being filed and consuming court resources for 82 days. IP risk programmes at large consumer goods companies should include automated docket alerts for any patent assertion, regardless of apparent relevance.
Rule 41(b) dismissals create durable defendant-side res judicata protection
A with-prejudice dismissal under Rule 41(b) is treated as a merits adjudication for res judicata purposes in the Ninth Circuit. Nike now holds a final judgment that bars re-litigation of these specific claims. Companies facing repeat pro se filers should evaluate whether to seek costs sanctions alongside the dismissal to create further deterrence.
Pro se patent filings in Oregon District Court: enforcement trends and screening tactics
The Oregon District Court has seen a pattern of unconventional patent filings. IP counsel advising Oregon-domiciled companies such as Nike should track pro se filing trends and consider pre-answer Rule 12 motions as a rapid resolution strategy when complaints fail basic pleading standards under Iqbal/Twombly.
Russ v Nike — key questions answered
Dismissed with prejudice under FRCP 41(b) means all of Jamaal Russ’s patent infringement claims against Nike are permanently terminated. The ruling operates as a merits adjudication — Russ cannot refile the same claims based on US6639128B1 against Nike in any federal court. The court first dismissed with leave to amend; Russ’s failure to amend triggered the final with-prejudice judgment.
US6639128B1 covers methods for altering organ mass, controlling fertility, and enhancing asexual reproduction in plants — an agricultural biotechnology patent. The basis for asserting it against Nike, a footwear and apparel company, is not apparent from the public docket. The complaint’s deficiencies were identified by Judge Immergut in ECF 14, but the specific insufficiencies were not publicly detailed before dismissal.
Federal Rule of Civil Procedure 41(b) allows a court to dismiss a case involuntarily when a plaintiff fails to prosecute or comply with a court order. In this case, Judge Immergut dismissed Russ’s petition with leave to amend via ECF 14. When Russ did not file an amended petition, the court invoked Rule 41(b) to enter final judgment dismissing all claims with prejudice for failure to prosecute.
Russ retains the right to appeal the Rule 41(b) dismissal to the Ninth Circuit Court of Appeals within the applicable deadline, arguing the court erred in dismissing with prejudice. However, refiling the same claims in district court is barred by the with-prejudice designation. A successful appeal would be required before any district court proceedings could resume.
No. The dismissal was entered on procedural failure-to-prosecute grounds — no merits ruling on the validity, scope, or infringement of US6639128B1 was made by the Oregon District Court. The patent remains nominally valid and enforceable. Third parties concerned about exposure to this patent should conduct an independent freedom-to-operate analysis and consider inter partes review if prior art grounds exist.
Run your FTO analysis on plant biology patents before it becomes a dispute
US6639128B1 was never invalidated or adjudicated on the merits. PatSnap Eureka helps R&D and IP teams assess exposure to active plant biotech patents, monitor new assertions, and build FTO reports before litigation risk materialises.
PatSnap Eureka searches patents and litigation data to answer instantly.